cagrilintide retatrutide combination trial Once-weekly for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 cagrilintide semaglutide trial We – www cagrilintide vs tirzepatide Combinations cagrilintide

In April 2025, Noom sponsored a back cover advertisement in the The Wall Street Journal calling for the creation of a High-Priced Drug List by HHS

Numerous regions of the brain express GLP-1 receptors which together synergistically impact food intake and reward-based behavior

It's massive, and it extends far beyond the number on the scale

A 2024 study published in the Journal of Clinical Investigation found that semaglutide reduced alcohol intake in people with AUD by approximately 30-40%

The 48-week data point At 48 weeks, participants in the 12 mg group had lost an average of 24.2% of body weight and the trajectory had not fully plateaued

Key points for patients: GLP-1 therapies help clear skin and reduce painful, swollen joints Obesity makes PsA harder to treat, so weight loss from GLP-1 meds helps In studies, patients on GLP-1s had fewer flares, less pain, and felt better overall